Bausch Health Companies Inc. (TSX:BHC)
Canada · Delayed Price · Currency is CAD | Market Cap | 3.60B |
| Revenue (ttm) | 13.97B |
| Net Income (ttm) | 504.23M |
| Shares Out | n/a |
| EPS (ttm) | 1.35 |
| PE Ratio | 7.14 |
| Forward PE | 1.68 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 438,749 |
| Average Volume | 481,716 |
| Open | 10.15 |
| Previous Close | 10.11 |
| Day's Range | 9.70 - 10.15 |
| 52-Week Range | 5.91 - 11.97 |
| Beta | 0.37 |
| RSI | 46.10 |
| Earnings Date | Feb 19, 2026 |
About Bausch Health Companies
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The Intern... [Read more]
Financial Performance
In 2024, Bausch Health Companies's revenue was $9.63 billion, an increase of 9.91% compared to the previous year's $8.76 billion. Losses were -$46.00 million, -92.23% less than in 2023.
Financial numbers in USD Financial StatementsNews
Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference
Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Bausch Health Companies Inc. (BHC) 44th Annual J.P.
Bausch Health Companies Inc at JPMorgan Healthcare Conference Transcript
Bausch Health Companies Inc at JPMorgan Healthcare Conference Transcript
Bausch Health (BHC) Raises 2025 Revenue and EBITDA Guidance
Bausch Health (BHC) Raises 2025 Revenue and EBITDA Guidance
Bausch Health sets 2025 outlook at the higher end of the prior range
Bausch Health (BHCO) stock in focus as the company set its full-year 2025 guidance at the higher end of the previously announced range. Read more here.
Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
LAVAL, QC, Jan. 5, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that Thomas J. Appio, Chief Executive Officer, will participate at the 44th Annual J.P.
Looking Into Bausch Health Companies Inc's Recent Short Interest
Bausch Health Companies Inc's (NYSE: BHC) short interest as a percent of float has risen 13.33% since its last report. According to exchange reported data, there are now 6.41 million shares sold shor...
Bausch Health Announces Final Results and Expiration of Exchange Offers
LAVAL, QC / ACCESS Newswire / December 23, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company") and its subsidiary 1261229 B.C. Ltd. (the "Issuer" and, together with the Company, th...
Fund Exits $6.6 Million Bausch + Lomb Stake as Shares Lag by 9% This Past Year
Strong operating results did not stop one fund from walking away entirely, raising questions about how much patience volatile healthcare names really command.
Bausch Health’s Slow Rebuild Faces New Scrutiny After Lombard Odier Cuts Its Stake
Bausch Health’s valuation suggests potential, but the stake cut shows how far the company still has to go to earn back full investor confidence.
Bausch Health Announces Early Exchange Offer Results for Exchange Offers
LAVAL, QC / ACCESS Newswire / December 8, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company") announced today the results to date of its previously announced offers to exchange the...
John Paulson's Strategic Acquisition in Bausch Health Companies Inc.
John Paulson's Strategic Acquisition in Bausch Health Companies Inc.
Bausch Health Companies Inc. (BHC) Presents at Evercore 8th Annual Healthcare Conference Transcript
Why Bausch Health Companies Stock Rocketed 11% Higher Today
Investors were obviously impressed with the company's latest acquisition.
Biggest Stock Movers Today, Dec. 1: BHC, SMR, & More
Major stock market indexes were down on Monday but closed well above their worst levels of the day. A healthcare stock was one of the best performers on the day.
Bausch Health (BHC) Shares Surge by Nearly 15%
Bausch Health (BHC) Shares Surge by Nearly 15%
Leggett & Platt, New Fortress Energy, Bausch Health Companies And Other Big Stocks Moving Higher On Monday
U.S. stocks were lower, with the Dow Jones falling around 250 points on Monday. Shares of Leggett & Platt Inc (NYSE: LEG) rose sharply during Monday's session r after it received a proposal from Somn...
Why Are Shares Of Bausch Health Up Today?
Shares of Bausch Health Companies Inc. (NASDAQ: BHC) are trading higher Monday after the company announced it acquired a technology firm through one of its subsidiaries . BHC stock is racing ahead of...
Bausch Health (BHC) Shares Surge Over 11% Amid Market Gains
Bausch Health (BHC) Shares Surge Over 11% Amid Market Gains
Bausch Health's Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China
Transaction boosts Solta Medical's position to meet rising demand in China's growing aesthetics market LAVAL, QC / ACCESS Newswire / December 1, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC)...
Do Options Traders Know Something About Bausch Health Stock We Don't?
Investors need to pay close attention to BHC stock based on the movements in the options market lately.
Bausch Health (BHC) Initiates Exchange Offer for Debt Management
Bausch Health (BHC) Initiates Exchange Offer for Debt Management
Bausch Health Announces Launch of Offers to Exchange Certain Existing Senior Secured Notes
LAVAL, QC / ACCESS Newswire / November 24, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") today announced the commencement of offers to exchange the Company...
Bausch (BHC) Upgraded to Buy: Here's Why
Bausch (BHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Bausch Health to Participate in the 8th Annual Evercore Healthcare Conference
LAVAL, QC / ACCESS Newswire / November 18, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that Jean-Jacques Charhon, Executive Vice President and Chief Financial Officer, wil...